DAX23.970 -1,0%ESt505.338 -0,3%Top 10 Crypto16,23 +2,0%Dow44.838 -0,1%Nas21.179 +0,3%Bitcoin101.668 ±0,0%Euro1,1596 ±0,0%Öl70,08 -0,5%Gold3.318 +0,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 Volkswagen (VW) vz. 766403 RENK RENK73 Mercedes-Benz Group (ex Daimler) 710000 Lufthansa 823212 Bayer BAY001 Deutsche Bank 514000 BASF BASF11 Tesla A1CX3T DroneShield A2DMAA Porsche PAG911 Novo Nordisk A3EU6F HENSOLDT HAG000 Deutsche Telekom 555750
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-EU-Zolldeal im Blick: DAX schließt unter 24.000 Punkten -- US-Börsen letztlich uneins -- NVIDIA-Aktie: Huawei stellt Konkurrenzsystem vor -- Tilray, TUI, Clara Tech, D-Wave, PUMA, Intel im Fokus
Top News
NVIDIA-Herausforderer FuriosaAI zieht großen Kunden an Land - War es das für die KI-Dominanz von NVIDIA? NVIDIA-Herausforderer FuriosaAI zieht großen Kunden an Land - War es das für die KI-Dominanz von NVIDIA?
BYD montiert E-Autos künftig auch in Pakistan - Tesla noch ohne Präsenz BYD montiert E-Autos künftig auch in Pakistan - Tesla noch ohne Präsenz
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Ãœbersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Roche Aktie

Handeln
279,66 EUR +1,25 EUR +0,45 %
BMN
260,60 CHF +1,40 CHF +0,54 %
SWX
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.221,58 Mrd. EUR

KGV24,60Div. Rendite3,80%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN855167

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINCH0012032048

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolRHHVF

Roche Aktien News

DatumMeistgelesen
Irish TimesMan missing in Wexford Harbour named locally as Brandon Roche (20)
Roche Holding AG[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong sales growth of 9% (CER) continues in the third quarter of 2024; Group sales increase 6% in the first nine months
GlobeNewswire[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong sales growth of 9% (CER) continues in the third quarter of 2024; Group sales increase 6% in the first nine months
ZacksThe Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi
GlobeNewswireRoche’s Vabysmo improved vision in underrepresented populations with diabetic macular edema (DME) in a first-of-its-kind study
Roche Holding AGRoche’s Vabysmo improved vision in underrepresented populations with diabetic macular edema (DME) in a first-of-its-kind study
PR NewswireRoche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY
ZacksRoche Wins FDA Nod for Breast Cancer Drug in First-Line Setting
GlobeNewswireMajority of children with spinal muscular atrophy (SMA) treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate
Roche Holding AGMajority of children with spinal muscular atrophy (SMA) treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate
GlobeNewswireFDA approves Roche’s Itovebi, a targeted treatment for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
Roche Holding AGFDA approves Roche’s Itovebi, a targeted treatment for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
GlobeNewswireRoche obtains CE certification for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY
Roche Holding AGRoche obtains CE certification for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY
Business TimesRoche will boost in-China production for local market: CEO
PR NewswireSurvey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public
PR NewswireSurvey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public
BenzingaDavid Roche Warns Of Market Instability From Fed's 50-Basis Point Cut: 'US Economy Is Robust...Does Not Need Rock Bottom Interest Rates'
ZacksRoche Ramps Up Breast Cancer Pipeline With Regor's CDK Inhibitors
BenzingaRoche Fast-Tracks Obesity Drug Development, Eyes Over $3B Sales Potential
Financial TimesRoche plans to launch drugs and slash development costs
Roche Holding AGPositive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy alone in people with lupus nephritis
GlobeNewswirePositive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy alone in people with lupus nephritis
Roche Holding AGRoche launches the first test to use its breakthrough TAGS technology for high throughput, simultaneous detection of 12 respiratory viruses
GlobeNewswireRoche launches the first test to use its breakthrough TAGS technology for high throughput, simultaneous detection of 12 respiratory viruses
GlobeNewswireWHO endorses dual-stain cytology (CINtec PLUS) testing in its cervical cancer prevention guidelines, advancing patient care and underlining Roche’s role in pioneering cervical cancer solutions
Roche Holding AGWHO endorses dual-stain cytology (CINtec PLUS) testing in its cervical cancer prevention guidelines, advancing patient care and underlining Roche’s role in pioneering cervical cancer solutions
ZacksRoche Antiviral Drug Reduces Transmission in Late-stage Study
GlobeNewswirePositive phase III results show Xofluza significantly reduces the transmission of influenza viruses
Roche Holding AGPositive phase III results show Xofluza significantly reduces the transmission of influenza viruses
GlobeNewswireFDA approves OCREVUS ZUNOVO™ as the first and only twice-a-year 10-minute subcutaneous injection for people with relapsing and progressive multiple sclerosis
Roche Holding AGFDA approves OCREVUS ZUNOVO™ as the first and only twice-a-year 10-minute subcutaneous injection for people with relapsing and progressive multiple sclerosis
Irish TimesGardaí to conduct fresh searches in Co Kilkenny for missing man Dean Roche
Financial TimesRoche data shows stomach-churning side effects of weight-loss drugs
ZacksRoche Gets FDA Approval for Subcutaneous Formulation of Tecentriq
ZacksRoche Stock to Benefit From Accu-Chek Smartguide Launch in Europe
Roche Holding AGFDA approves Roche’s Tecentriq Hybreza, the first and only subcutaneous anti-PD-(L)1 cancer immunotherapy
GlobeNewswireFDA approves Roche’s Tecentriq Hybreza, the first and only subcutaneous anti-PD-(L)1 cancer immunotherapy
ZacksRoche Stock Down on Concerns of Side-Effects From Its Obesity Drug
MotleyFoolWhy Roche Holdings Stock Withered on Wednesday

Roche News

Roche News: auf dieser Seite finden Sie alle Roche News und Nachrichten zur Roche Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Roche News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Roche News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.